These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 1753683)

  • 21. Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.
    Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Côrtes SF; Duarte ID
    Anesth Analg; 2011 Nov; 113(5):1254-9. PubMed ID: 21788321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats.
    Schneider R; Raff U; Vornberger N; Schmidt M; Freund R; Reber M; Schramm L; Gambaryan S; Wanner C; Schmidt HH; Galle J
    Kidney Int; 2003 Jul; 64(1):216-25. PubMed ID: 12787412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thirty Years of Saying NO: Sources, Fate, Actions, and Misfortunes of the Endothelium-Derived Vasodilator Mediator.
    Vanhoutte PM; Zhao Y; Xu A; Leung SW
    Circ Res; 2016 Jul; 119(2):375-96. PubMed ID: 27390338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide-dependent renal vasodilatation is not altered in rat with rHuEpo-induced hypertension.
    Migliori M; Taccola D; Panichi V; De Pietro S; Andreini B; Di Benedetto A; Filippi C; Palla R; Giovannini L
    Kidney Blood Press Res; 1999; 22(3):140-5. PubMed ID: 10394113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide in the regulation of renal blood flow.
    Ito S; Carretero OA; Abe K
    New Horiz; 1995 Nov; 3(4):615-23. PubMed ID: 8574592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial dysfunction and vascular disease.
    Vanhoutte PM
    Verh K Acad Geneeskd Belg; 1998; 60(3):251-66. PubMed ID: 9803882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M; Santisteban J; Finckenberg P; Salmenperä P; Riutta A; Moilanen E; Virtanen I; Vapaatalo H; Nurminen ML
    J Physiol Pharmacol; 2001 Mar; 52(1):21-38. PubMed ID: 11321510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aging and severity of hypertension attenuate endothelium-dependent renal vascular relaxation in humans.
    Higashi Y; Oshima T; Ozono R; Matsuura H; Kajiyama G
    Hypertension; 1997 Aug; 30(2 Pt 1):252-8. PubMed ID: 9260989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of endothelial dysfunction in hypertension.
    Lüscher TF
    Eur Heart J; 1992 Sep; 13 Suppl D():50-5. PubMed ID: 1396860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathogenetic aspects of the L-arginine-NO metabolic pathway in arteriosclerosis and possible therapeutic aspects].
    Böger RH; Bode-Böger SM; Frölich JC
    Vasa; 1996; 25(4):305-16. PubMed ID: 9036707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of renal perfusion pressure on renal interstitial hydrostatic pressure and Na+ excretion: role of endothelium-derived nitric oxide.
    Nakamura T; Alberola AM; Salazar FJ; Saito Y; Kurashina T; Granger JP; Nagai R
    Nephron; 1998; 78(1):104-11. PubMed ID: 9453411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal endothelial dysfunction and hypertension.
    Higashi Y; Chayama K
    J Diabetes Complications; 2002; 16(1):103-7. PubMed ID: 11872376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin.
    Fleming I; Julou-Schaeffer G; Gray GA; Parratt JR; Stoclet JC
    Br J Pharmacol; 1991 May; 103(1):1047-52. PubMed ID: 1678981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.
    Yao SK; Ober JC; Krishnaswami A; Ferguson JJ; Anderson HV; Golino P; Buja LM; Willerson JT
    Circulation; 1992 Oct; 86(4):1302-9. PubMed ID: 1394936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of endothelial nitric oxide in the regulation of the vasomotor system].
    Michel JB
    Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial nitric oxide synthase gene polymorphisms and the renal hemodynamic response to L-arginine.
    Cherney DZ; Scholey JW; Zhou J; Zimpelmann J; Kennedy C; Burns KD; Lai V; Miller JA
    Kidney Int; 2009 Feb; 75(3):327-32. PubMed ID: 19037250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitric oxide modulates vascular disease in the remnant kidney model.
    Kang DH; Nakagawa T; Feng L; Johnson RJ
    Am J Pathol; 2002 Jul; 161(1):239-48. PubMed ID: 12107108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is atherosclerosis an arginine deficiency disease?
    Cooke JP
    J Investig Med; 1998 Oct; 46(8):377-80. PubMed ID: 9805422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canine renovascular responses to sumatriptan and 5-carboxamidotryptamine: modulation through endothelial 5-HT1-like receptors by endogenous nitric oxide.
    Whiting MV; Cambridge D
    Br J Pharmacol; 1995 Mar; 114(5):969-74. PubMed ID: 7780652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.